Results 311 to 320 of about 221,455 (333)
Some of the next articles are maybe not open access.

Rituximab and Risk of Second Primary Malignancies in Patients With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis

Annals of Oncology, 2016
Sylvie Chevret   +2 more
exaly  

High Incidence of Non-Neutropenic Infections Induced by Rituximab Plus Fludarabine and Associated With Hypogammaglobulinemia: A Frequently Unrecognized and Easily Treatable Complication

Annals of Oncology, 2006
Fernando Cabanillas
exaly  

Rituximab

Reactions Weekly
  +5 more sources

Paradoxical Increases in Serum IgM and Viscosity Levels Following Rituximab in Waldenstrom's Macroglobulinemia

Annals of Oncology, 2004
Steven P. Treon   +2 more
exaly  

Extended Rituximab Therapy in Waldenström's Macroglobulinemia

Annals of Oncology, 2005
Steven P. Treon, K C Anderson, F Preffer
exaly  

Rituximab

Reactions Weekly, 2009
openaire   +1 more source

Japanese Multicenter Phase II and Pharmacokinetic Study of Rituximab in Relapsed or Refractory Patients With Aggressive B-Cell Lymphoma

Annals of Oncology, 2004
Yukio Kobayashi, K Tsushita
exaly  

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

The Lancet Oncology, 2006
M. Pfreundschuh   +23 more
semanticscholar   +1 more source

Rituximab: A Benchmark in the Development of Chemotherapy-Free Treatment Strategies for Follicular Lymphomas

Annals of Oncology, 2018
Emanuele Zucca, Reem Karmali, Leo Gordon
exaly  

Rituximab Monotherapy for Primary Cutaneous B-Cell Lymphoma: Response and Follow-Up in 16 Patients

Annals of Oncology, 2009
Julia Valencak   +2 more
exaly  
diseases of the blood and blood-forming organs
immunologic diseases
allergy
membranous nephropathy
nephrotic syndrome
previous   30  31  32  33  34  

Home - About - Disclaimer - Privacy